Business ❯Pharmaceutical Industry ❯Market Trends

Drug Development

Competition Investment Opportunities Healthcare Costs Eli Lilly & Co. Clinical Trials Strategic Alliances

Cipla Prepares to Enter India’s Weight Management Market as It Expands CNS and AMR Portfolios

Strong FY25 profits are backing Cipla’s launch of obesity drugs alongside growth in CNS offerings, novel AMR therapies.

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Roche Accelerates Development of Promising Weight-Loss Pills